Delivery Order SPE2DB20D3303-SPE2DB25FA0GD
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xifaxan 550 mg tablets (60-count) valued at $17,574.14 under a firm fixed-price contract. This award, issued on August 26, 2025, represents a non-set-aside competitive procurement and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The delivery order has an ultimate completion date of August 27,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,445.16 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,324.37 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price delivery order, which was not set-aside and competitively awarded, is scheduled for completion by August 12, 2025, with performance at the company's Conshohocken location. The award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,206.44 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was made through open competition...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,380.43 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of August 5, 2025. The award reflects AmerisourceBergen's established role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,910.72 delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $58,117.57 by the Defense Logistics Agency's Medical Supply Chain on June 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion on June 10, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $275,058.03 on April 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 24, 2025, and carries no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 2, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for $1,859.79 under firm fixed price terms. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 3, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,490.76 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0GDDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 16, 2025, for 60 tablets of Xifaxan 550 mg with a ceiling value of $6,393.88. This competitive award with firm fixed pricing represents a child order under the company's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle that runs through December 2026. The delivery order carries an ultimate completion date of June 17, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. This award reflects AmerisourceBergen's established role as a critical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. The company's DLA Troop Support contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. As a non-set-aside competitive award, this delivery order demonstrates the contractor's continued capability to meet federal procurement requirements in the competitive pharmaceutical distribution marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/16/25 |